Investor's Business Daily on MSN

CRISPR Therapeutics stock sees RS rating rise to 73

CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced the launch of its Early Access Express License, a ...
In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and ...
Chinese scientists using CRISPR/Cas9 technology have created a tomato with a flavor reminiscent of fresh buttery popcorn.
In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and soil degradation, in addition ...
At an event on Monday, the agency officially unveiled long-awaited draft guidance meant to help speed the development of bespoke treatments for extremely rare diseases.
In a research greenhouse in eastern China’s Zhejiang province, the tomatoes looked ordinary, but they carried a surprisingly sweet scent – the aroma of buttered popcorn. It was not the result of ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.
As the world races toward 10 billion people, farming is being reinvented by machines, data, and biology, from robotic harvesters and satellite monitoring to vertical growing and gene-edited crops.
The Pairwise Fulcrum® platform includes proprietary gene editing tools, enzymes, and trait libraries that enable precise genetic changes, unlocking plants’ inherent potential and significantly ...
The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are ...